AU2001284791A1 - Gp64-null baculoviruses pseudotyped with heterologous envelope proteins - Google Patents

Gp64-null baculoviruses pseudotyped with heterologous envelope proteins

Info

Publication number
AU2001284791A1
AU2001284791A1 AU2001284791A AU8479101A AU2001284791A1 AU 2001284791 A1 AU2001284791 A1 AU 2001284791A1 AU 2001284791 A AU2001284791 A AU 2001284791A AU 8479101 A AU8479101 A AU 8479101A AU 2001284791 A1 AU2001284791 A1 AU 2001284791A1
Authority
AU
Australia
Prior art keywords
pseudotyped
baculoviruses
null
envelope proteins
heterologous envelope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001284791A
Inventor
Gary Blissard
Jodie Mangor
Scott Monsma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boyce Thompson Institute for Plant Research Inc
Original Assignee
THOMPSON BOYCE PLANT RES
Boyce Thompson Institute for Plant Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by THOMPSON BOYCE PLANT RES, Boyce Thompson Institute for Plant Research Inc filed Critical THOMPSON BOYCE PLANT RES
Publication of AU2001284791A1 publication Critical patent/AU2001284791A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001284791A 2000-08-11 2001-08-09 Gp64-null baculoviruses pseudotyped with heterologous envelope proteins Abandoned AU2001284791A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22461200P 2000-08-11 2000-08-11
US60/224,612 2000-08-11
PCT/US2001/025047 WO2002014527A2 (en) 2000-08-11 2001-08-09 Gp64-null baculoviruses pseudotyped with heterologous envelope proteins

Publications (1)

Publication Number Publication Date
AU2001284791A1 true AU2001284791A1 (en) 2002-02-25

Family

ID=22841411

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001284791A Abandoned AU2001284791A1 (en) 2000-08-11 2001-08-09 Gp64-null baculoviruses pseudotyped with heterologous envelope proteins

Country Status (3)

Country Link
US (2) US6607912B2 (en)
AU (1) AU2001284791A1 (en)
WO (1) WO2002014527A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7416890B2 (en) * 2002-09-25 2008-08-26 Osaka Industrial Promotion Organization Baculovirus vector, method of producing thereof and method of gene transfer
JP4431039B2 (en) * 2002-09-25 2010-03-10 財団法人大阪産業振興機構 Baculovirus vector, baculovirus vector production method and gene introduction method
EP2301573A1 (en) * 2002-10-01 2011-03-30 Novartis Vaccines and Diagnostics, Inc. Anti-cancer and anti-infectious disease compositions and methods for using same
US20080311147A1 (en) * 2004-04-19 2008-12-18 Thomas Jeffeson University Rhabdoviral N-Fusion Proteins as Carrier for Foreign Antigens
US9333249B2 (en) 2006-02-09 2016-05-10 Educational Foundation Jichi Medical University Recombinant baculovirus vaccine
TWI477602B (en) 2006-02-09 2015-03-21 Educational Foundation Jichi Medical Univ Novel viral vector
WO2007149946A2 (en) * 2006-06-20 2007-12-27 Invitrogen Corporation Composition and methods for expressing reporter molecules in mammalian cells
US8703469B2 (en) 2007-07-06 2014-04-22 Boyce Thompson Institute For Plant Research Baculoviruses with enhanced virion production and a method for the production of baculoviruses
WO2009014878A2 (en) * 2007-07-06 2009-01-29 Boyce Thompson Institute For Plant Research Baculoviruses with enhanced virion production and a method for the production of baculoviruses
EP2568289A3 (en) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
US9347065B2 (en) 2012-03-29 2016-05-24 International Aids Vaccine Initiative Methods to improve vector expression and genetic stability
GB201319791D0 (en) * 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750383A (en) * 1996-05-14 1998-05-12 Boyce Thompson Institute For Plant Research, Inc. Baculovirus cloning system
JP2001508645A (en) 1996-09-11 2001-07-03 ザ ジェネラル ホスピタル コーポレーション Non-mammalian DNA virus with altered coat protein
DE19735593C2 (en) 1997-08-15 1999-08-26 Hepavec Ag Fuer Gentherapie Coat protein-modified baculovirus vector for gene therapy
JP2003527816A (en) 1998-07-24 2003-09-24 アバンテイス・フアルマ・エス・アー Baculovirus-derived vector and use of the vector to introduce nucleic acids into vertebrate neurons

Also Published As

Publication number Publication date
US20020115188A1 (en) 2002-08-22
WO2002014527A3 (en) 2003-04-24
US6607912B2 (en) 2003-08-19
WO2002014527A2 (en) 2002-02-21
US6858205B2 (en) 2005-02-22
US20040009153A1 (en) 2004-01-15

Similar Documents

Publication Publication Date Title
AU2002312410A1 (en) Tissue-specific endothelial membrane proteins
AU2001291049A1 (en) Defensin-antigen fusion proteins
EP1130098A3 (en) Mammalian osteoregulins
AU2001284791A1 (en) Gp64-null baculoviruses pseudotyped with heterologous envelope proteins
AU2001279535A1 (en) Bone-regeneration material
AU2001239773A1 (en) Baroplastic materials
AU2001290220A1 (en) High level expression of heterologous proteins
AU2001272750A1 (en) Tumor-specific promoters
AU2001284418A1 (en) Novel polypeptide
AU2001291050A1 (en) Viral chemokine-tumur antigen fusion proteins
AUPR126500A0 (en) Documents envelope
AU2002232707A1 (en) Transmembrane proteins
AU2002239291A1 (en) G protein coupled receptors
AU2002310969A1 (en) Reporter virus comprising heterologous envelope proteins
AU7049601A (en) Ceramic material
AU2002239747A1 (en) Cystoskeleton-associated proteins
AU6983000A (en) Chimeric proteins
AU2001244863A1 (en) Apoptin-associating protein
AU2001264307A1 (en) Envelope
AU2002224379A1 (en) Clasp-2 transmembrane proteins
AU7060201A (en) Transparent envelope
AU2002222124A1 (en) Reinforced material
AU3181401A (en) Chemically modified hiv envelope glycoprotein
AU2002224056A1 (en) Novel polypeptide
AU2002316348A1 (en) Chimeric capsid proteins and uses thereof